← Open Payments lookup

EVELYN MAJOR: Open Payments

NPI 1023623519 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,084 in 44 payments from 16 companies in 2025. Trend: 2023 $2,221 · 2024 $2,158 · 2025 $1,084

Food & beverage: $1,084
CompanyPaymentsAmount
Phathom Pharmaceuticals, Inc.4$141
Gilead Sciences, Inc.5$139
ABBVIE INC.6$134
PFIZER INC.5$112
Janssen Biotech, Inc.4$109
Ipsen Biopharmaceuticals, Inc3$70
Takeda Pharmaceuticals U.S.A., Inc.3$65
Ardelyx, Inc.2$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$56
Intercept Pharmaceuticals, Inc.2$44

Products named: VOQUEZNA, TREMFYA, IQIRVO, XELJANZ, ENTYVIO, IBSRELA, XIFAXAN, VELSIPITY.

Industry payments across MD — which companies pay providers there.